Janet E Paulsen

Title: Janet E Paulsen: Innovator in Biopharmaceuticals

Introduction

Janet E Paulsen is a notable inventor based in Londonderry, NH (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of engineered proteins and therapeutic antibodies. With a total of 2 patents, her work has the potential to impact various medical applications.

Latest Patents

Janet's latest patents include innovations in bispecific antibodies and modulators of gluconeogenesis. The bispecific antibodies patent focuses on engineered heteromultimeric proteins, detailing methods for producing and purifying these proteins for use in diagnostics and therapeutics. Additionally, it introduces a humanized antibody that specifically binds to human TrkB, which can be utilized in treating hearing loss disorders. The second patent on modulators of gluconeogenesis provides methods for affecting gluconeogenesis by altering the levels or activity of DUSP4 and/or EGR1, along with pharmaceutical compositions that comprise or encode these modulators.

Career Highlights

Throughout her career, Janet has worked with prominent companies such as Pfizer Corporation and Wyeth. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the biopharmaceutical sector.

Collaborations

Janet has collaborated with esteemed colleagues, including Ruth E Gimeno and Eric M Bennett. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Janet E Paulsen is a distinguished inventor whose work in biopharmaceuticals continues to pave the way for new therapeutic solutions. Her patents reflect her commitment to innovation and her impact on the medical field.